| Financial Year |
March 31 2023 |
| Monetary Funds |
457,007,726.90 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
24,847,724.10 |
| Advances to Suppliers |
9,560,235.10 |
| Other Receivables |
6,998,876.75 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
-- |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
3,810,708.17 |
| Total Current Assets |
516,289,796.23 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
82,020,890.00 |
| Investment Properties |
-- |
| Fixed Assetes |
2,705,183.39 |
| Under-construction Projects |
-- |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
18,027,191.54 |
| R&D expenses |
16,788,337.83 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
9,387,253.88 |
| Deferred Income Tax Assets |
6,679,469.60 |
| Other Non-Current Assets |
44,879,515.63 |
| Sub-Total of Non-Current Assets |
247,945,051.62 |
| Total Assets |
764,234,847.85 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
35,609,696.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
18,776,590.23 |
| Taxes Payable |
7,537,420.83 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
12,675,076.42 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
14,730,093.28 |
| Other Current Liabilities |
5,250,195.63 |
| Sub-Total of Current Liabilities |
210,917,413.05 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
16,582,282.88 |
| Total Liabilities |
227,499,695.93 |
| Paid-In Capital(Or Share Stock) |
167,379,464.00 |
| Capital Surplus |
368,371,820.22 |
| Surplus Reserve |
9,914,666.01 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-9,165,426.12 |
| Minority Stockholder's Interest |
234,627.81 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
536,500,524.11 |
| Owner's Equity（Stockholder's Equity） |
536,735,151.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
764,234,847.85 |
